Back

Orthopaedic red flags at time of diagnosis and disease severity in patients with cardiac amyloidosis

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Clinical perspectives in cardiac amyloidosis Hypertrophic Cardiomyopathy Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Yu Fu Ferrari Chen

Sant'Anna School of Advanced Studies, Pisa (Italy)

6 More presentations in this session

Presentation thumbnail
Exploration of arrhythmia burden in cardiac amyloidosis using implantable loop recorders (the EXACLIBUR trial)
Doctor A. Ioannou (Greater London, GB) Doctor A. Sheikh (London, GB)
Abstract Slides
Presentation thumbnail
Myocardial fibrosis in cardiac amyloidosis: evidence from left ventricular endomyocardial biopsies
Doctor A. Aimo (Pisa, IT)
Abstract Slides
Presentation thumbnail
18F-Florbetaben-PET/CT extracardiac uptake in patients with suspected cardiac amyloidosis: prevalence, distribution, and prognostic significance
Mr P. Morfino (Pisa, IT) Doctor V. Castiglione (Pisa, IT)
Abstract Slides
Presentation thumbnail
99mTC-DPD bone scintigraphy in ATTR-CM: are we missing patients? can you suggest me more titles?
Mr D. Ferreira (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Aortic valve stenosis is unrelated to the severity of transthyretin amyloid cardiomyopathy and is instead linked to aging
Doctor A. Okada (Osaka, JP)
Abstract Slides

Access the full session

Session thumbnail
Clinical perspectives in cardiac amyloidosis

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources